Anna Meyfour
Impact in
Papers in
-
- Congenital heart defects research 3
- Extracellular vesicles in disease 3
- Glycosylation and Glycoproteins Research 2
- Pluripotent Stem Cells Research 2
- Genetics 5
- Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities 4
- Genetics and Neurodevelopmental Disorders 3
- Co-authors
- Ghasem Hosseini Salekdeh (12 shared papers)Sara Pahlavan (9 shared papers)Hossein Baharvand (6 shared papers)Meghdad Abdollahpour‐Alitappeh (4 shared papers)Mehdi Mirzaei (6 shared papers)Hassan Ansari (2 shared papers)Faezeh Shekari (4 shared papers)Mostafa Rezaei–Tavirani (3 shared papers)
In The Last Decade
Anna Meyfour
28 papers receiving 398 citations
Peers
Comparison fields: 5 of 72
- Cancer Research 43
- Virology 13
- Oncology 66
- Molecular Biology 173
- Genetics 58
Countries citing papers authored by Anna Meyfour
This map shows the geographic impact of Anna Meyfour's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Meyfour with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Meyfour more than expected).
Fields of papers citing papers by Anna Meyfour
This network shows the impact of papers produced by Anna Meyfour. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Meyfour. The network helps show where Anna Meyfour may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Meyfour, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 49 | |
| 2 | 2021 | 46 | |
| 3 | 2017 | 34 | |
| 4 | 2022 | 22 | |
| 5 | 2024 | 22 | |
| 6 | 2019 | 19 | |
| 7 | 2023 | 17 | |
| 8 | 2024 | 17 | |
| 9 | 2020 | 16 | |
| 10 | 2021 | 15 | |
| 11 | Contribution of NOTCH signaling pathway along with TNF-α in the intestinal inflammation of ulcerative colitis. | 2019 | 15 |
| 12 | 2020 | 15 | |
| 13 | 2017 | 15 | |
| 14 | 2020 | 13 | |
| 15 | 2020 | 12 | |
| 16 | 2021 | 11 | |
| 17 | 2022 | 10 | |
| 18 | 2020 | 9 | |
| 19 | 2022 | 8 | |
| 20 | 2023 | 7 |
About Anna Meyfour
Anna Meyfour is a scholar working on Molecular Biology, Genetics, Immunology, Oncology and Spectroscopy, having authored 30 papers that have together received 402 indexed citations. Recurring topics across this work include Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (4 papers), Advanced Proteomics Techniques and Applications (3 papers), Genetics and Neurodevelopmental Disorders (3 papers), Congenital heart defects research (3 papers), Extracellular vesicles in disease (3 papers), Glycosylation and Glycoproteins Research (2 papers), Pluripotent Stem Cells Research (2 papers) and Rabies epidemiology and control (2 papers). The work is most often cited by research in Cancer Research (43 citations), Virology (13 citations), Oncology (66 citations), Molecular Biology (173 citations) and Genetics (58 citations). Anna Meyfour has collaborated with scholars based in Iran, Australia and Iraq. Frequent co-authors include Ghasem Hosseini Salekdeh, Sara Pahlavan, Hossein Baharvand, Meghdad Abdollahpour‐Alitappeh, Mehdi Mirzaei, Hassan Ansari, Faezeh Shekari, Mostafa Rezaei–Tavirani, Vivek Gupta and Hamid Gourabi. Their work appears in journals such as Journal of Proteome Research, Molecular Therapy, Cellular and Molecular Life Sciences, Life Sciences and Aging and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.